Works matching AU Shu, Kuo-Hsiung


Results: 47
    1
    2

    Everolimus‐facilitated calcineurin inhibitor reduction in Asian de novo kidney transplant recipients: 2‐year results from the subgroup analysis of the TRANSFORM study.

    Published in:
    Clinical Transplantation, 2021, v. 35, n. 10, p. 1, doi. 10.1111/ctr.14415
    By:
    • Watarai, Yoshihiko;
    • Danguilan, Romina;
    • Casasola, Concesa;
    • Chang, Shen‐Shin;
    • Ruangkanchanasetr, Prajej;
    • Kee, Terence;
    • Wong, Hin Seng;
    • Kenmochi, Takashi;
    • Amante, Angel Joaquin;
    • Shu, Kuo‐Hsiung;
    • Ingsathit, Atiporn;
    • Bernhardt, Peter;
    • Hernandez‐Gutierrez, Maria Pilar;
    • Han, Duck Jong;
    • Kim, Myoung Soo
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9

    Effects of Sustained‐Release Beraprost in Patients With Primary Glomerular Disease or Nephrosclerosis: CASSIOPEIR Study Results.

    Published in:
    Therapeutic Apheresis & Dialysis, 2020, v. 24, n. 1, p. 42, doi. 10.1111/1744-9987.12840
    By:
    • Nakamoto, Hidetomo;
    • Yu, Xue‐Qing;
    • Kim, Suhnggwon;
    • Origasa, Hideki;
    • Zheng, Hongguang;
    • Chen, Jianghua;
    • Joo, Kwon Wook;
    • Sritippayawan, Suchai;
    • Chen, Qinkai;
    • Chen, Hung‐Chun;
    • Tsubakihara, Yoshiharu;
    • Tamai, Hirofumi;
    • Song, Sang Heon;
    • Vaithilingam, Indralingam;
    • Lee, Kang Wook;
    • Shu, Kuo‐Hsiung;
    • Hok‐King Lo, Stanley;
    • Isono, Masanao;
    • Kurumatani, Hajimu;
    • Okada, Kiyonobu
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47